Arctic Pharma AS is a privately held company founded in 2012 by shareholders and employees of Spermatech AS. Our mission is to make Arctic Pharma a leader in designing cancer therapies that are environmentally friendly and have few side effects. 

We have performed a modern drug discovery project searching for potent and novel inhibitors of the Warburg effect. In this work, we have screened more than 300,000 drug-like compounds in biochemical and biological assays. This has resulted in approximately 100 promising hit compounds. Some advanced hits have been generated by medicinal chemistry. Pilot studies have demonstrated that several of our compounds are potent inhibitors of cancer cell growth.